Realizing the Potential of Virtual Patient Simulation With Real-World Outcomes
September 18, 2024 |
We’re celebrating Healthcare Simulation Week 2024 by highlighting the transformative power of our multi-award-winning medical simulation programs, which have proven impact in delivering significant improvements in clinical skills and outcomes.
In this latest article we dive into the growth of virtual patient simulations and share insights from our Chief Impact Officer, Katie S Lucero. Discover how integrating real-world outcomes tools is enhancing healthcare providers’ experiences and driving better patient care.
Simulation is a vital component of medical education and is increasingly being used in postgraduate settings for practicing clinicians who are training and certifying learners to assess their knowledge, skills, and confidence in real-life healthcare settings and ultimately, improve patient outcomes.
Spurred on by the COVID-19 pandemic, an increased focus on patient safety, the growing demand for minimally invasive treatments, and advancements in technology, the demand for virtual patient simulation continues to grow. By 2028, the virtual simulation market is expected to reach 8.97 billion.
Although virtual simulation programs can provide education evaluators with valuable data about learners’ actions, including areas where they made improvements and where learning gaps remain, real-world outcomes are a critical aspect that should be integrated into any program.
“We know that programs measure impact using real-world outcomes are one of the few ways to understand whether knowledge, skills, and/or self-efficacy learners have acquired is being applied in the real world, ultimately leading to better patient outcomes,” according to Katie Lucero, PhD, Chief Impact Officer, Medscape Education.
The Importance of Real-World Outcomes
Virtual patient simulation has a number of use cases and allows practicing healthcare professionals an opportunity to interview and examine patients, order tests and exams, deliver interventions, and observe the patient’s response to therapy in real time.
Research also shows that virtual patient simulation can improve clinical decision-making. In fact, according to a 2022 systematic review and meta-analysis, nursing students and nurses who utilized virtual simulation demonstrated a significant improvement in clinical reasoning based on applied knowledge and clinical performance compared to learners in the control group.
Outcome measurements derived from virtual simulation programs can provide rich quantitative and qualitative data, including correct and incorrect responses, pre- and post-intervention assessments, and learner evaluations tied to specific educational objectives.
Although these data allow supervising physicians to quickly and easily understand the impact of the program by comparing learners’ baseline knowledge to improvements after interventions are delivered, they only capture short-term outcomes. “To determine the long-term efficacy of the program, education evaluators must examine how learners applied their newfound knowledge in clinical practice,” Lucero said.
Affecting Behavior Change With Medscape Real-World Outcomes
Real-World Outcomes, an advanced Medscape assessment approach, works by analyzing learners’ behaviors in the real world before and after they participate in the education activity. The tool can determine if the knowledge they acquired has been applied in the real world to ensure a positive impact on patients over a longer period of time.
Our research shows while learners may answer questions correctly after completing a module, for example, fewer learners are exhibiting behavior change in the real world. “While this doesn’t mean that the education was ineffective, it may reveal insights into what worked for whom and and why to inform education strategy over time,” Lucero said. Our MedSims virtual patient simulation solution and Real-World Outcomes tool have been shown to positively affect behavior change. In fact, a 2023 studyin the journal JMIR Medical Education, which aimed to evaluate the effect of the MedSims VPS platform on the real-world selection of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for type-2 diabetes, found the CME resulted in a 29 percentage point increase in correct decisions from pre to post feedback. The study also found that the learners were 4 times more likely to select guideline-based treatment for patients after CME than the control group.
What’s more, a 2020 instructional design studyby the Calibre Institute for Quality Medical Education found 5 activities representing various therapeutic areas in the MedSims solution have a high potential to engage physicians and lead to improvements in practice.
At Medscape Education, we not only deliver impact, we guarantee it. Our virtual patient simulation programs have been proven in multiple studies to improve care and drive better decision-making. With the backing of Real-World Outcomes methods, we know MedSims has the power to change patient care.
“When clinicians participate in simulation programs, we see a significant improvement in skills, confidence, and behavior change,” according to Lucero. “With Real-World Outcomes, we have a powerful set of data that we’re leveraging to evolve our programs and advance our outcomes research which will only improve the education we can provide clinicians.”
For more information on MedSims and Real-World Outcomes, contact your local Medscape representative or one of our team leads:
For the US please contact: Piyali Chatterjee-Shin , Jess Dropkin, David Anderson or Chris Carey
For OUS please contact: Peter Schoonheim or Jelena Spyropoulos
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Medscape Education and M4RD: Together Caring for Rare Disease
We are excited to finally share our news-style video ' ', developed in partnership with Medics 4 Rare Diseases (M4RD) and produced by Genetic Alliance UK and ITN Business.For more information on...
The Need for and Impact of Rare Disease Education
Physicians are often told that when they hear hoofbeats, think horses, not zebras — to look for the most common cause of a patient’s symptoms first. While this advice may...
Medscape Education: Rare Diseases Fibrodysplasia Ossificans Progressiva
Rare Disease Day is on February 28.Listen to Nicky explain her daughter's journey with fibrodysplasia ossificans progressiva.Many patients face long waits for accurate diagnosis and treatment, making it critically important...
Medscape Education: Rare Diseases
It's only a few days until #RareDiseaseDay2023 on 28th February. We're taking a patient centered approach, this means understanding their journey so we can better understand how we can help to...
Together Caring for Rare Disease
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
Medscape Education Wins Best Practice Award for Learner Outcomes at NAMEC
This year's winners have been announced for the National Association of Medical Education Companies (NAMEC) awards. These awards recognize best practices-ideas or processes that can be implemented by NAMEC members to...
Medscape Education and Medics4RareDisease Uncover the Education Gaps in Their Compelling Rare Disease Day Campaign
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?
Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...
DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE
During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...
ESMO’s New Focus on Cancer Prevention
During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),...